NBIX

NASDAQ · Biotechnology

Neurocrine Biosciences Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$131.13

+3.27 (+2.56%)

As of Mar 25, 9:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 86%

Hold 5 14%

Sell 0 0%

Price Target

Analyst Price Target -3.2% upside

Low Target $104.30

Average Target $126.93

High Target $177.55

Current Price $131.13

Current
$131.13

Target
$126.93

$104.30 $126.93 avg $177.55

Scenario Analysis

Bear Case

$104.30

-20.5%

Low target

Base Case

$126.93

-3.2%

Avg target

Bull Case

$177.55

+35.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$160.18

-18.1% from high

52-Week Low

$84.23

+55.7% from low

50-Day SMA

$139.44

-6.0% vs SMA

200-Day SMA

$135.94

-3.5% vs SMA

RSI (14)

38.6

Neutral

Target vs 52W High

$126.93

-20.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%